- Telehealth Visits
- Insurance plan information
James Lin, MD
- Telehealth Visits
- Insurance plan information
James Lin, MD
- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Internal Medicine, American Board of Internal Medicine
Residency
- Internal Medicine, Kaiser Permanente Santa Clara Medical Center
Component Name: Provider Research Listing component built but no clinical trials or publications to display
Clinical Trials query: q=health_gateway_id_ss%3A%28%223493%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%223493%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Showing 1-6 of 8 reviews
Sort by
- November 1, 20255 out of 5 Stars
Great experience with Dr. Lin
- July 28, 20255 out of 5 Stars
Dr. Lin is fantastic
- July 25, 20255 out of 5 Stars
Excellent care, did research on my concerns before the visit and was well prepared!!
- April 23, 20255 out of 5 Stars
Dr Lin is excellent
- March 10, 20255 out of 5 Stars
The care provider was kind and caring
- February 24, 20255 out of 5 Stars
Excellent active listening skills; experienced diagnostician
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.